Oorsprong van het eerstegraads netwerk van Ferdinando Nicoletti
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
OncoNOx ApS
 OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark.
5
| Holding Company | Pharmaceuticals: Major | 5 |
University of Catania
5
| College/University | Other Consumer Services | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ferdinando Nicoletti via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chief Executive Officer Chairman | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| GALECTO, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
| Stanford University | College/University | Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member | |
| University of Southern Denmark | College/University | Doctorate Degree | |
| IO BIOTECH, INC. | Biotechnology | Founder | |
| UNIPOLSAI ASSICURAZIONI S.P.A. | Multi-Line Insurance | Director/Board Member | |
| Associazione Civilisti Italiani | Director/Board Member | ||
| Agenzia Nazionale di Valutazione del Sistema Universitario | College/University | Corporate Officer/Principal | |
| Osservatorio del Diritto Civile e Commerciale | Founder | ||
| European University Institute | College/University | Doctorate Degree | |
| Ordine degli Avvocati di Catania | Corporate Officer/Principal | ||
Trenitalia SpA
 Trenitalia SpA RailroadsTransportation Trenitalia SpA engages in the provision of rail passenger transport and logistics services. The firm offers regional and long-haul passenger trips and cargo transport. The company was founded in 2000 and is headquartered in Rome, Italy. | Railroads | Director/Board Member | |
Arbitro Bancario Finanziario
 Arbitro Bancario Finanziario Miscellaneous Commercial ServicesCommercial Services Arbitro Bancario Finanziario provides arbitration services. The non-profit company is based in Milan, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MAPS S.P.A. | Packaged Software | Director/Board Member | |
| European Research Centre | Corporate Officer/Principal | ||
| SOCIETÀ INIZIATIVE AUTOSTRADALI E SERVIZI S.P.A. | Other Transportation | Director/Board Member | |
| Éupolis Lombardia | College/University | Graduate Degree | |
| University of Turin | College/University | Doctorate Degree | |
| European College of Veterinary Public Health | College/University | Corporate Officer/Principal | |
| Centro di Referenza per le Encefalopatie Animali | Corporate Officer/Principal | ||
| Centro Interdipartimentale di Studi Avanzati di Neuroscienze | Corporate Officer/Principal | ||
Compagnia di San Paolo
 Compagnia di San Paolo MiscellaneousMiscellaneous Compagnia di San Paolo operates as a foundation, which engages in the promotion of cultural, civil and economic development. It specializes in research and education; the arts; cultural heritage and activities; health; and social policy. The company was founded on January 25, 1563 and is headquartered in Turin, Italy. | Miscellaneous | Corporate Officer/Principal | |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| CREDITO VALTELLINESE S.P.A. | Major Banks | Director/Board Member | |
| University of Reggio Calabria | College/University | Corporate Officer/Principal | |
TM Consulting SRL
 TM Consulting SRL Regional BanksFinance TM Consulting SRL provides electronic processing of accounting data for third parties. The private company is based in Castel Guelfo di Bologna, Italy. | Regional Banks | Director/Board Member | |
Proterris (Portugal) - Investigação e Desenvolvimento
 Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
| Roche Corp. | Corporate Officer/Principal | ||
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| University of Milan | College/University | Doctorate Degree | |
The Wistar Institute
 The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | Corporate Officer/Principal | |
| Fondazione Irccs Istituto Nazionale Dei Tumori | College/University | Corporate Officer/Principal | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
Natimab Therapeutics Srl
 Natimab Therapeutics Srl BiotechnologyHealth Technology Natimab Therapeutics Srl operates as a biotechnology company. It specializes in the identification and early-stage clinical development of monoclonal antibodies (mAbs) for the treatment of infectious diseases. The company was founded by Gianni Garotta, Maurizio Denaro, Marianne Murphy and Gerritt Hagens in 2009 and is headquartered in Colleretto Giacosa, Italy. | Biotechnology | Chief Executive Officer | |
| Commissione Tributaria Regionale Della Sicilia | Corporate Officer/Principal |
Statistieken
Internationaal
| Italië | 25 |
| Denemarken | 12 |
| Verenigde Staten | 8 |
| Zwitserland | 3 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 19 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 4 |
| Transportation | 3 |
Operationeel
| Corporate Officer/Principal | 38 |
| Director/Board Member | 23 |
| Founder | 12 |
| Chief Executive Officer | 10 |
| Doctorate Degree | 9 |
Sterkste connecties
| Insiders | |
|---|---|
| Hans Schambye | 16 |
| Mai-Britt Zocca | 13 |
| Gianni Garotta | 12 |
| Gianvito Giannelli | 12 |
| Maria Rosaria Maugeri | 11 |
| Maria Caramelli | 9 |
| Giovanni Continella | 3 |
| Vito Branca | 3 |
| Marco Donia | 2 |
| Yousef Al-Abed | 1 |
- Beurs
- Insiders
- Ferdinando Nicoletti
- Bedrijfsconnecties
